MICROSEMI CORPORATION
Summary of Schedule Reconciling Selected Non-GAAP Financial Measures
to Comparable GAAP Financial Measures
(unaudited, in millions, except for per share amounts)

Quarter Ended September 29, 2013

GAAP

Non-GAAP Adjustments

Non-GAAP

Net sales

$

250.4

$

—

$

250.4

Gross profit

$

142.8

$

—

$

142.8

Operating income

$

26.9

$

32.3

$

59.2

Net income

$

14.1

$

35.0

$

49.1

Diluted earnings per share

$

0.15

$

0.38

$

0.53

MICROSEMI CORPORATION
Consolidated Condensed Statement of Income
(unaudited, in millions, except per share amounts)

Quarter Ended

Twelve Months Ended

Sep 29,

2013

Jun 30,

2013

Sep 30,

2012

Sep 29,

2013

Sep 30,

2012

Net sales

$

250.4

$

242.6

$

263.1

$

975.9

$

1,012.5

Cost of sales

107.6

104.3

112.7

418.7

459.9

Gross profit

$

142.8

$

138.3

$

150.4

$

557.2

$

552.6

Operating expenses

Selling, general and administrative

$

49.9

$

48.8

$

53.6

$

202.5

$

205.0

Research and development

43.2

42.2

42.8

170.6

168.5

Amortization of intangible assets

21.0

21.0

27.4

84.8

104.8

Restructuring charges

1.8

1.1

(0.5)

9.9

8.7

Acquisition costs

—

—

0.5

—

7.3

Total operating expenses

$

115.9

$

113.1

$

123.8

$

467.8

$

494.3

Operating income

$

26.9

$

25.2

$

26.6

$

89.4

$

58.3

Interest and other (expense), net

(6.7)

(7.0)

(8.6)

(33.3)

(73.0)

Income (loss) before income taxes

$

20.2

$

18.2

$

18.0

$

56.1

$

(14.7)

Provision (benefit) for income taxes

6.1

(0.1)

6.4

12.4

15.0

Net income (loss)

$

14.1

$

18.3

$

11.6

$

43.7

$

(29.7)

Earnings (loss) per share

Basic

$

0.16

$

0.20

$

0.13

$

0.49

$

(0.35)

Diluted

$

0.15

$

0.20

$

0.13

$

0.48

$

(0.35)

Weighted-average common shares outstanding

Basic

90.4

89.8

86.5

89.5

85.8

Diluted

92.8

91.7

88.8

91.3

85.8